International Clinical Trials Day 2026: Advancing the Future of Healthcare

Today, May 20, is International Clinical Trials Day - an opportunity to raise awareness about the importance of clinical research and its contribution to advances in healthcare.

Do you know when and who executed the first clinical trial?

The Scottish physician James Lind is considered the first physician to conduct a controlled clinical trial in the modern era in 1747, when he set out to find a cure for scurvy among sailors.

Why are clinical trials so important? They are extremely valuable since they support:

• Development of treatments for people with diseases or conditions who previously had few or no therapeutic options;

• The raise of standard of care for many conditions and diseases;

• Guidance and improvement of patient care;

• Evaluation of both the safety and efficacy of treatments;

• Reduction of bias through controlled and evidence-based research methods.

Here at ID-CARE we run several clinical studies (you can discover more here), including the randomised clinical trial OPTICOV (OPtimization of antiviral Therapy in Immunocompromised COVID-19 patients: a randomized factorial controlled strategy trial), part of the EU-RESPONSE Project (GA 101015736).

The randomised controlled OPTICOV study evaluates the efficacy of a combined antiviral regimen and of extending oral antiviral treatment from 5 to 10 days for the treatment of COVID-19 in immunocompromised patients, a vulnerable population at high risk of developing severe forms of infection. We are pleased to announce that in Verona, the first patient was enrolled on April 24, 2026.

Clinical trials are the foundation of medical innovation. Every breakthrough treatment, vaccine, and therapy we rely on today was once part of a clinical study. By advancing scientific knowledge and improving patient outcomes, clinical research continues to shape a healthier future for everyone.